Max Healthcare Shareholders Approve ₹1.5 Dividend and Key Resolutions at 24th AGM
The announcement covers routine AGM proceedings, including the approval of financial statements and re-appointment of directors, along with a standard dividend declaration. These are expected corporate actions and typically have a low immediate market impact.
The approval of all proposed resolutions, including the declaration of a final dividend and the adoption of financial statements, indicates stable corporate governance and a positive outcome for shareholders.
Max Healthcare Institute Limited held its 24th Annual General Meeting (AGM) on Wednesday, 30 July 2025, through video conference and other audio-visual means.
Shareholders duly passed all eight resolutions as set out in the Notice of 24th AGM dated 20 May 2025. Key resolutions approved include: * Adoption of the Audited Standalone Financial Statements for the financial year 2024-25. * Adoption of the Audited Consolidated Financial Statements for the financial year 2024-25. * Declaration of a final dividend of ₹1.5 (i.e., 15%) per equity share of face value of ₹10 each. * Re-appointment of Mr. Anil Kumar Bhatnagar as a Director, who retired by rotation. * Continuation of Mr. Anil Kumar Bhatnagar as Non-Executive Director of the Company. * Appointment of M/s. S.R. Batliboi & Co. LLP, Chartered Accountants, as the Statutory Auditors of the Company. * Appointment of M/s. DPV & Associates LLP, Practicing Company Secretaries, as Secretarial Auditor of the Company. * Ratification of remuneration payable to Cost Auditors for the financial year 2025-26.
All resolutions were passed with the requisite majority, as confirmed by the scrutinizer’s report dated 30 July 2025.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under corporate actions. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.